The Maot Group is a venture capital and consulting company dedicated to investing in a responsible and ethical manner and focused on nanotechnology, biotechnology, and general high-tech. Since its founding in 1991, The Maot Group and its affiliated entities have built an exceptionally well-diversified investment portfolio under the leadership of its founding partner and managing director, Aryeh Rubin. Additionally, The Maot Group consults with investors and investment groups with the objective of discerning opportunities in advanced technology. The diversity, acuity, and creativity evidenced in The Maot Group’s portfolio are indicative of its leadership’s strategic vision and tactical expertise.
The Maot Group invests both directly and through partners. In the past, The Maot Group and its affiliated entities invested in opportunities in the United States and abroad, from real estate to restaurants, from electronics to hi-tech disease therapies, from oil and gas to concrete. The diversity, acuity, and creativity represented by The Maot Group’s portfolio are reflective of its leadership’s strategic vision and expert tactical execution.
While it still has interests in the above categories of investments, since 2008 The Maot Group has focused its investments in the areas of advanced technology in both the United States and Israel.
The Maot Group continues to search for new opportunities in the technological fields; its network provides a consistent source of possibilities and Group employees and/or consultants attend conferences looking for innovative companies. In the recent past, representatives have been present at several conferences, including: Journey High Tech Conference, Tel Aviv; Noble Financial Healthcare, Hollywood, Florida; Rodman and Renshaw (sponsored by HC Wainwright), New York; Piper Jaffray Healthcare, New York; Oppenheimer Technology Conference, New York; and Jefferies Healthcare, New York.
This website includes a selected list of The Maot Group’s investments, a review of which will reveal common traits of profitability, quality, and continued promise.